{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-005736","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2024-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.271532+00:00","generated_at":"2026-06-06T04:54:41.272257+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Intelligent Bio Solutions Q2 revenue up 114% YoY to $0.76M; net loss widens","bullets":["Revenue from sales of goods increased 114% to $0.76M in Q2 FY2024, and 337% to $1.56M for six months ended Dec 31, 2023.","Net loss attributable to INBS for six months was $4.39M, compared to $1.63M in prior year, driven by acquisition of IFP.","Company raised ~$4.38M in October 2023 public offering; net proceeds ~$3.79M; ended quarter with $1.12M cash.","Expanded into New Zealand market; customer portfolio includes VKVP Haulage, Titan Cranes, P&O Ferries; NATA accreditation for confirmatory drug testing.","Product sales grew 30% for cartridges and 91% for readers in six months; management expects continued rapid growth in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-005736","json":"https://secwatch.observer/filing/0001493152-24-005736.json","markdown":"https://secwatch.observer/filing/0001493152-24-005736.md","text":"https://secwatch.observer/filing/0001493152-24-005736.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224005736/0001493152-24-005736-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224005736/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T04:54:41.272257+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fdf33b6eb5a7a7a3d842faf00716ea33e3ce20b1","claim":"INTELLIGENT BIO SOLUTIONS INC. reported financial results for fiscal second quarter and six months ended December 31, 2023.","evidence_excerpt":"On February 9, 2024, Intelligent Bio Solutions Inc. (the “Company”), issued a press release (the “Press Release”) announcing financial results for the three months ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224005736/0001493152-24-005736-index.htm","confidence":0.8,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal second quarter and six months ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}